Forbes June 29, 2024
Sai Balasubramanian, M.D., J.D.

Walgreens is one of the most celebrated names in the retail pharmacy space, boasting innovation and convenience for its customers. However, in its latest earnings report, the company announced a tough financial environment and outlook, citing “a worse-than-expected U.S. consumer environment.”

Without a doubt, inflation has struck Americans at all levels—from the rise in costs of groceries and food to skyrocketing housing payments and insurance rates. Consumer sentiment towards the retail space has been especially challenging, as individuals are starting to pullback on discretionary spending. As CEO Tim Wentworth explained, these economic headwinds have significantly impacted pharmacy margins, causing a pessimistic outlook for the company.

In addition to closing down some “under-performing stores,” the company also announced that it would...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Primary care, Provider
Eli Lilly Puts $1B on the Line to Expand its Cancer Radiopharmaceuticals Prospects
STAT+: Pharmalittle: We’re reading about indicted drug wholesalers, a gene therapy rejection, and more
On Parachutes And Vaccines
STAT+: After months of warnings, FTC opens investigation into Teva over ‘improper’ patents
As Walgreens Closes Stores, Turnaround May Take ‘Quarters, Not Months’

Share This Article